Study Stopped
slow accrual
Acupuncture for the Treatment of Cancer Related Fatigue
A Phase II Study of Acupuncture for the Treatment of Cancer Related Fatigue in Children and Adolescents With Central Nervous System Tumors
1 other identifier
interventional
7
1 country
1
Brief Summary
Cancer-related fatigue occurs in both adult and pediatric patients undergoing chemotherapy and/or radiation. Recently, methods to measure fatigue have improved - however, no non-medication interventions have been studied. Ameliorating fatigue may result in an improved quality of life for patients. Acupuncture is a safe and well-tolerated procedure and has been used for many indications in pediatric patients. Adult studies have suggested improvement in cancer-related fatigue after acupuncture in adults. In this trial, we propose using acupuncture for the treatment in cancer-related fatigue in children and adolescents with central nervous system tumors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Sep 2011
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 24, 2012
CompletedFirst Posted
Study publicly available on registry
April 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 5, 2016
February 1, 2016
4.3 years
February 24, 2012
February 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cancer-related fatigue
Participants will be on-study for up to 14 weeks. . No follow-up will be required after the completion of the study.
Study Arms (1)
Acupuncture
EXPERIMENTALEight sessions of weekly acupuncture
Interventions
Eligibility Criteria
You may qualify if:
- Patients who are ≥ 8 year of age and ≤ 21 years of age who are undergoing chemotherapy and/or radiation therapy for the treatment of any primary or recurrent central nervous system tumor (regardless of diagnosis or disease stage, whether it is malignant or benign, and in any location) at Children's Memorial Hospital.
- Patients who recently completed therapy (within 60 days of enrollment) will also be eligible. Patients must have a minimum baseline fatigue score of 15 on the pedsFACIT-F scale (Range 0-44). This is not a standard assessment for required clinical care and will only be administered by a research assistant to any patient after consent has been obtained. The assessment will be done during a routine clinic visit.
- For patients receiving cytotoxic chemotherapy with a history of myelosuppression or radiation, a hemoglobin concentration of \>8 g/dL measured within 10 days of enrollment and a platelet count of \> 30,000 within 5 days of enrollment is required.
- Patients must also be able to read and understand English and read a computer screen.
- Patients with no known contraindications to acupuncture therapy.
- Patients who are able to attend all scheduled visits for acupuncture.
- Patients must have a Karnofsky Performance Score of ≥ 50% or a Lansky Performance Score of ≥ 50.
- Patients who have provided informed consent for the research study (parental consent for patients \< 18 years of age). Patients between 12 years and 18 years of age must provide assent in additional to parental consents.
You may not qualify if:
- Patients with evidence of any cognitive dysfunction that would limit their abilities to report fatigue.
- Patients who have received acupuncture in the previous six weeks.
- Patients with a life expectancy \< 3 months.
- Patients who are pregnant or lactating.
- Patients with a past history of therapy or scheduled visits non-compliance, as determined by their treating physician.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, 60611, United States
Related Publications (7)
Cella D, Davis K, Breitbart W, Curt G; Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001 Jul 15;19(14):3385-91. doi: 10.1200/JCO.2001.19.14.3385.
PMID: 11454886BACKGROUNDLai JS, Cella D, Kupst MJ, Holm S, Kelly ME, Bode RK, Goldman S. Measuring fatigue for children with cancer: development and validation of the pediatric Functional Assessment of Chronic Illness Therapy-Fatigue (pedsFACIT-F). J Pediatr Hematol Oncol. 2007 Jul;29(7):471-9. doi: 10.1097/MPH.0b013e318095057a.
PMID: 17609625BACKGROUNDLibonate J, Evans S, Tsao JC. Efficacy of acupuncture for health conditions in children: a review. ScientificWorldJournal. 2008 Jul 13;8:670-82. doi: 10.1100/tsw.2008.86.
PMID: 18661055BACKGROUNDJindal V, Ge A, Mansky PJ. Safety and efficacy of acupuncture in children: a review of the evidence. J Pediatr Hematol Oncol. 2008 Jun;30(6):431-42. doi: 10.1097/MPH.0b013e318165b2cc.
PMID: 18525459BACKGROUNDMolassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med. 2007 Dec;15(4):228-37. doi: 10.1016/j.ctim.2006.09.009. Epub 2006 Nov 13.
PMID: 18054724BACKGROUNDBalk J, Day R, Rosenzweig M, Beriwal S. Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol. 2009 Winter;7(1):4-11.
PMID: 19476729BACKGROUNDMatecki, A.a.I., David, Acupunture for the Treatment of Chronic Post-Chemotherapy Fatigue. ClinicalTrials.gov, 2008: p. NCT00658034.
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rishi Lilla, MD
Ann & Robert H Lurie Children's Hospital of Chicago
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
February 24, 2012
First Posted
April 6, 2012
Study Start
September 1, 2011
Primary Completion
December 1, 2015
Study Completion
December 1, 2015
Last Updated
February 5, 2016
Record last verified: 2016-02